U.S. Senate panel probing Valeant, Turing over drug costs
Source: Reuters
A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical pricing, seeking documents from four drugmakers including Valeant Pharmaceuticals and Turing Pharmaceuticals, companies embroiled in controversy over price hikes on lifesaving drugs.
The Senate's Special Committee on Aging also requested information from Retrophin Inc and Rodelis Therapeutics, according to a statement from the panel's Republican Chairwoman Susan Collins and Claire McCaskill, its top Democrat.
Also on Wednesday, Democratic members of a U.S. House of Representatives investigative committee asked Republicans to call a vote to subpoena Valeant and Turing.
These Democratic leaders called for an investigation of drug prices in September, emboldened by press reports of a more than 5000 percent overnight increase in a toxoplasmosis drug made by Turing and a more than 600 percent increase in a blood pressure treatment from Valeant.
[font size=1]-snip-[/font]
Read more: http://www.reuters.com/article/2015/11/04/us-usa-congress-drugprices-idUSKCN0ST1S220151104
US | Wed Nov 4, 2015 1:10pm EST
NEW YORK/WASHINGTON | BY CAROLINE HUMER AND SARAH N. LYNCH
= new reply since forum marked as read
Who knows? 
